Episodes

  • HCM Practice Essentials: Management Essentials

    HCM Practice Essentials: Management Essentials
    Jun 25 2024
    In this episode, Prof Juan Pablo Kaski is joined by Dr Carolyn Ho, join them in this 20-minute discussion on essential management topics, including phenotyping, triaging, symptomatic care, and transplant considerations.
    Show more Show less
    27 mins
  • HCM Practice Essentials: Patient and Family Support

    HCM Practice Essentials: Patient and Family Support
    May 31 2024
    In this episode, Prof Juan Pablo Kaski is joined by Dr Jodie Ingles and Dr Elena Biagini to discuss long-term management, expectations in cardiology, community care and family genetic screening. Tune in for expert insights on supporting patients and their families.
    Show more Show less
    25 mins
  • View from the Thoraxcenter: EuroPCR 24 Late-breaking Science Preview

    View from the Thoraxcenter: EuroPCR 24 Late-breaking Science Preview
    May 7 2024
    What's hot at EuroPCR 2024? Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting. What is the potential impact of the new data on practice? What details should we look out for? What is the context of the EuroPCR trials? Trials covered included: 00:46 - CAREER 02:03 - Angiography-based Radial Wall Strain in Predicting Non-Culprit Vessel Failure 04:05 - DOCTORS-LM 07:41 - TCW 09:35 - SOLVE-TAVI 12:27 - NOTION-2 14:41 - LANDMARK 16:36 - AltaValve 17:53 - LuxValvePlus 19:12 - CALIPSO 21:44 - ROTA-ISR 23:57 - ROLLERCOASTR 25:20 - Balloon Angioplasty Vs Shockwave Intravascular Lithotripsy 25:29 - OCT Vs IVUS
    Show more Show less
    26 mins
  • HCM Practice Essentials: Setting-up an HCM Clinic

    HCM Practice Essentials: Setting-up an HCM Clinic
    Apr 30 2024
    In the first episode, Prof Juan Pablo Kaski and Prof Ruxandra Jurcut discuss the essentials of establishing an HCM Clinic, covering its objectives, logistical aspects, systemic challenges, and operational strategies, including referral practices and collaboration with specialist centres.
    Show more Show less
    19 mins
  • View from the Thoraxcenter: ACC.24 Late-breaking Science Wrap Up

    View from the Thoraxcenter: ACC.24 Late-breaking Science Wrap Up
    Apr 12 2024
    Unpack ACC.24's Top Trials with View from the Thoraxcenter! Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive into the late-breaking data presented at ACC.24. In this thought-provoking ACC 2024 wrap-up, delve into the nuances of the most impactful trials, gaining insights into their implications for current practice and future research directions. 00:29 - Ultimate DAPT 02:49 - IVUS-ACS 04:22 - RELIEVE-HF 08:00 - ORBITA-COSMIC 11:12 - EMPACT-MI 14:36 - REDUCE-AMI 17:51 - DEDICATE-DZHK6 22:32 - SMART 26:26 - PREVENT 29:08 - FULL REVASC 33:43 - DanGer Shock 39:44 - TARGET BP I
    Show more Show less
    44 mins
  • Very-High Power Short Duration Vs Conventional Ablation for PVI in AF

    Very-High Power Short Duration Vs Conventional Ablation for PVI in AF
    Dec 14 2023
    In this episode of the Radcliffe Podcast, we are joined by Dr Raymond Pranata, Dr Mohammad Iqbal and Dr Giky Karwiky (Hasan Sadikin General Hospital, Bandung, Indonesia) as they discuss their recently published systematic review and meta-analysis of very-high-power short-duration ablation as compared to conventional ablation for the treatment of pulmonary vein isolation in atrial fibrillation. 13 studies were included in their analysis, which found that VHPSD ablation was associated with lower AF recurrence as compared to the conventional ablation group. Subgroup analysis showed that additional ablation beyond PVI had a similar rate of AF recurrence compared to PVI alone. If you have any questions or suggestions, please email managingeditor@ecrjournal.com.
    Show more Show less
    30 mins
  • View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

    View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up
    Nov 20 2023
    What's hot at #AHA23? Join Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) as they review the latest late-breaking science data from AHA Scientific Sessions 2023. They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research. Trials Covered include: 00:20 - DAPA-MI: Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack 06:30 - ORBITA-2: Percutaneous Coronary Intervention for Stable Angina: A Randomised, Placebo-Controlled Trial 12:39 - A Sub-Analysis of the Prospective ECLS-Shock Trial 16:13 - ARTESiA: Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation 10:02 - SELECT: Semaglutide and Cardiovascular Outcomes in Patients With Overweight or Obesity Who Do Not Have Diabetes We value your opinion! Share your feedback by commenting on this page or sending us an email at info@radcliffe-group.com.
    Show more Show less
    23 mins
  • View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up

    View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up
    Oct 27 2023
    What are the top late-breaking trials from #TCT2023? TCT 2023 — Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference. Dive into this practical and engaging discussion and learn more about the latest data for practice and for research. We value your opinion! Share your feedback by commenting on this page or sending us an email at info@radcliffe-group.com. Trials covered: 00:20 - PARTNER 3 Low-Risk: Five-Year Clinical and Echocardiographic Outcomes 01:47 - EVOLUT Low-Risk: Four-Year Outcomes From the EVOLUT Low Risk Trial 04:02 - ALIGN-AR: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement 06:18 - VIVA: Transcatheter versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annuli 08:19 - AGENT IDE: Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT 11:56 - DCB-ACS: Drug-Coated Balloon for Acute Coronary Syndromes 14:06 - T-PASS: Less Than 1-month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy after Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome 16:40 - WATCH TAVR: Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve 19:20 - TRILUMINATE: Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation 21:13 - TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients With Severe Tricuspid Regurgitation 23:23 - PICSO-AMI-I: Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction 26:07 - RADIANCE: Individual Patient-data Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months
    Show more Show less
    31 mins